Mitsubishi Tanabe Pharma Partners With UiPath To Improve Business Operations and Efficiency

UiPath , a leading enterprise automation software company, today announced that Mitsubishi Tanabe Pharma Corporation, a leading Japanese pharmaceuticals company, has turned to the UiPath Business Automation Platform to improve business operational...

Octapharma USA Applies For Approval Of Wilate Supplements

Octapharma USA has submitted a Biologics License Application Supplement (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the approval of wilate, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for ...

GenScript ProBio, RVAC Medicines collabrates for GMP plasmid DNA manufacturing for mRNA Covid-19 vaccine candidate

RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of messenger RNA (mRNA) therapeutics and vaccines, and GenScript ProBio, a leading global Contract Development and Manufacturing Organization...

India's Biocon raises $129 million from Kotak to fund biosimilars deal

The asset management arm of India's Kotak Mahindra Group said it will invest 10.70 billion rupees ($129 million) in Biocon Ltd to help it fund its acquisition of Viatris Inc's biosimilars business. In late November, Biocon Biologics completed...

Malaria No More inks MoU with Odisha govt to amplify malaria elimination efforts

Malaria No More (MNM) has signed a Memorandum of Understanding (MoU) with the Government of Odisha's Department of Health and Family Welfare to eradicate malaria from the state...

DoKaSch Temperature Solutions and ANA sign master rental agreement

All Nippon Airways (ANA), the Japanese largest airline, and DoKaSch Temperature Solutions have signed a Master Rental Agreement. The German specialist for active temperature-controlled packaging solutions is henceforth providing its Opticooler....

WHO grants prequalification GC Biopharma's varicella vaccine, Barycela

The World Health Organization (WHO) has granted prequalification for the firm's varicella vaccine, Barycela, according to GC Biopharma, a leading provider of biopharmaceutical products in South Korea...

Gland Pharma to invest Rs 400 Cr to expand its Telangana plant

Gland Pharma announced today that it will invest Rs 400 crore to expand its existing facility in Genome Valley here to manufacture biologicals, biosimilars, antibodies, and recombinant insulin. According to a state government press release, the...

BioNTech sees UK trials on cancer vaccines starting this year

Clinical trials for BioNTech's cancer vaccines are expected to begin this year in the United Kingdom, marking an important step towards their possible sale on the open market, according to the German company's top executive, Ugur Sahin, in the...

Sun Pharma acquires minority stakes in two healthcare firms for Rs 180 crore

Sun Pharmaceutical Industries Ltd., one of India's leading pharmaceutical companies, has announced the acquisition of a 26.09% stake in digital health startups Agatsa Software Pvt. Ltd. and Remidio Innovative Solutions Pvt. Ltd. The move is part...

© 2025 India Pharma Outlook. All Rights Reserved.